Metoprolol

"Metoprolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Descriptor ID	D008790
MeSH Number(s)	D02.033.100.624.698.573 D02.033.755.624.698.573 D02.092.063.624.698.573
Concept/Terms	Metoprolol Metoprolol Betalok Betalok CGP-2175 CGP-2175 CGP 2175 CGP2175 H 93-26 H 93-26 H 93 26 H 9326 Lopressor Lopressor Beloc-Duriles Beloc-Duriles Beloc Duriles BelocDuriles Seloken Seloken Spesicor Spesicor Spesikor Metoprolol Succinate Metoprolol Succinate Succinate, Metoprolol Metoprolol CR-XL CR-XL, Metoprolol Metoprolol CR XL Toprol-XL Toprol-XL Toprol XL ToprolXL Toprol Betaloc Betaloc Betaloc-Astra Betaloc Astra BetalocAstra Metoprolol Tartrate Metoprolol Tartrate Tartrate, Metoprolol

Below are MeSH descriptors whose meaning is more general than "Metoprolol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Propanolamines [D02.033.100.624]
Phenoxypropanolamines [D02.033.100.624.698]
Metoprolol [D02.033.100.624.698.573]
Propanols [D02.033.755]
Propanolamines [D02.033.755.624]
Phenoxypropanolamines [D02.033.755.624.698]
Metoprolol [D02.033.755.624.698.573]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Propanolamines [D02.092.063.624]
Phenoxypropanolamines [D02.092.063.624.698]
Metoprolol [D02.092.063.624.698.573]

Below are MeSH descriptors whose meaning is related to "Metoprolol".

Below are MeSH descriptors whose meaning is more specific than "Metoprolol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Metoprolol" by people in this website by year, and whether "Metoprolol" was a major or minor topic of these publications.

Bar chart showing 13 publications over 9 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2007	1	0	1
2009	2	0	2
2014	1	0	1
2015	1	0	1
2017	1	1	2
2019	1	2	3
2020	0	1	1
2025	1	0	1

Below are the most recent publications written about "Metoprolol" by people in Profiles.

Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Pe?a-Pe?a ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Hegde SM, Lakdawala NK, Lewis GD, Mann A, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025 Sep 11; 393(10):949-960.

View in: PubMed
Sahu KK, Mishra AK, Doshi A, Martin KB. Heart broken twice: a case of recurrent Takatsubo cardiomyopathy. BMJ Case Rep. 2020 Jan 07; 13(1).

View in: PubMed
Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoglu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE. Metoprolol for the Prevention of Acute Exacerbations of COPD. N Engl J Med. 2019 12 12; 381(24):2304-2314.

View in: PubMed
Singh S, Warren HR, Hiltunen TP, McDonough CW, El Rouby N, Salvi E, Wang Z, Garofalidou T, Fyhrquist F, Kontula KK, Glorioso V, Zaninello R, Glorioso N, Pepine CJ, Munroe PB, Turner ST, Chapman AB, Boerwinkle E, Johnson JA, Gong Y, Cooper-DeHoff RM. Genome-Wide Meta-Analysis of Blood Pressure Response to ?1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies). J Am Heart Assoc. 2019 08 20; 8(16):e013115.

View in: PubMed
Singh S, El Rouby N, McDonough CW, Gong Y, Bailey KR, Boerwinkle E, Chapman AB, Gums JG, Turner ST, Cooper-DeHoff RM, Johnson JA. Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans. Clin Transl Sci. 2019 09; 12(5):497-504.

View in: PubMed
Hallengren E, Almgren P, Rosvall M, ?stling G, Persson M, Bergmann A, Struck J, Engstr?m G, Hedblad B, Melander O. Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment. BMC Cardiovasc Disord. 2017 05 16; 17(1):125.

View in: PubMed
Meoli EM, Goldsweig AM, Malm BJ. Acute Myocardial Infarction from Coronary Vasospasm Precipitated by Pseudoephedrine and Metoprolol Use. Can J Cardiol. 2017 05; 33(5):688.e1-688.e3.

View in: PubMed
Ryu RJ, Eyal S, Easterling TR, Caritis SN, Venkataraman R, Hankins G, Rytting E, Thummel K, Kelly EJ, Risler L, Phillips B, Honaker MT, Shen DD, Hebert MF. Pharmacokinetics of metoprolol during pregnancy and lactation. J Clin Pharmacol. 2016 May; 56(5):581-9.

View in: PubMed
Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, Raj SR, Robertson D, Biaggioni I. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension. 2014 Dec; 64(6):1241-7.

View in: PubMed
Herman M, Donovan J, Tran M, McKenna B, Gore JM, Goldberg RJ, Tighe DA. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target? Am Heart J. 2009 Sep; 158(3):378-85.

View in: PubMed

People

Explore

Similar Concepts

Top Journals